These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2350533)

  • 21. Pharmacokinetics of midazolam in Vietnamese subjects.
    Balson KR; Morgan DJ; Richmond BH; McAlindon ME; Elliott SL; Yeomans ND
    J Gastroenterol Hepatol; 1996 Dec; 11(12):1177-80. PubMed ID: 9034939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration.
    Clausen TG; Wolff J; Hansen PB; Larsen F; Rasmussen SN; Dixon JS; Crevoisier C
    Br J Clin Pharmacol; 1988 Apr; 25(4):457-63. PubMed ID: 3382589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced distribution and clearance of acetaminophen in patients with congestive heart failure.
    Ochs HR; Schuppan U; Greenblatt DJ; Abernethy DR
    J Cardiovasc Pharmacol; 1983; 5(4):697-9. PubMed ID: 6193370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing sedation following major vascular surgery: a double-blind study of midazolam administered by continuous infusion.
    Miller DR; Martineau RJ; Hull KA; Vallée F; LeBel M
    Can J Anaesth; 1994 Sep; 41(9):782-93. PubMed ID: 7954994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetic studies following intravenous and rectal administration of midazolam in children].
    Kraus GB; Gruber RG; Knoll R; Danner U
    Anaesthesist; 1989 Dec; 38(12):658-63. PubMed ID: 2619028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and pharmacodynamics of midazolam following intravenous and intramuscular administration to sheep.
    Simon BT; Scallan EM; O O; Ebner LS; Cerullo MN; Follette C; Cox SK; Doherty TJ; Lizarraga I
    Am J Vet Res; 2017 May; 78(5):539-549. PubMed ID: 28441044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam.
    Bodmer M; Link B; Grignaschi N; Kummer O; Ruegg S; Haschke M; Krähenbühl S
    Ther Drug Monit; 2008 Feb; 30(1):120-4. PubMed ID: 18223475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxaprozin pharmacokinetics in patients with congestive heart failure.
    Ochs HR; Greenblatt DJ; Knüchel M
    Arzneimittelforschung; 1986 Dec; 36(12):1837-40. PubMed ID: 3566846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology of single- and multiple-ascending doses of ACT-178882, a new direct renin inhibitor, and its pharmacokinetic interaction with food and midazolam.
    Dingemanse J; Nicolas L; Binkert C
    Fundam Clin Pharmacol; 2013 Dec; 27(6):698-710. PubMed ID: 22849770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.
    Shord SS; Chan LN; Camp JR; Vasquez EM; Jeong HY; Molokie RE; Baum CL; Xie H
    Br J Clin Pharmacol; 2010 Feb; 69(2):160-6. PubMed ID: 20233179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of desipramine on norepinephrine clearance in congestive heart failure.
    Clemson B; Baily RG; Davis D; Zelis R
    Am J Physiol; 1990 Aug; 259(2 Pt 1):E261-5. PubMed ID: 2200276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
    Zimmermann T; Yeates RA; Laufen H; Scharpf F; Leitold M; Wildfeuer A
    Arzneimittelforschung; 1996 Feb; 46(2):213-7. PubMed ID: 8720318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of prazosin.
    Jaillon P
    Clin Pharmacokinet; 1980; 5(4):365-76. PubMed ID: 6994981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of midazolam used as an intravenous induction agent for patients over 80 years of age.
    Servin F; Enriquez I; Fournet M; Failler JM; Farinotti R; Desmonts JM
    Eur J Anaesthesiol; 1987 Jan; 4(1):1-7. PubMed ID: 3582373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midazolam microdose to determine systemic and pre-systemic metabolic CYP3A activity in humans.
    Hohmann N; Kocheise F; Carls A; Burhenne J; Haefeli WE; Mikus G
    Br J Clin Pharmacol; 2015 Feb; 79(2):278-85. PubMed ID: 25588320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between midazolam and clarithromycin in the elderly.
    Quinney SK; Haehner BD; Rhoades MB; Lin Z; Gorski JC; Hall SD
    Br J Clin Pharmacol; 2008 Jan; 65(1):98-109. PubMed ID: 17635500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
    Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration.
    Rey E; Delaunay L; Pons G; Murat I; Richard MO; Saint-Maurice C; Olive G
    Eur J Clin Pharmacol; 1991; 41(4):355-7. PubMed ID: 1804652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.